参考文献
参考文献
F.Scogin, D.Hamblin, and L.Beutler, “Bibliotherapy for Depressed Older Adults: A Self-Help Alternative,”The Gerontologist 27 (1987): 383–387.
F.Scogin, C.Jamison, and K.Gochneaut, “The Comparative Efficacy of Cognitive and Behavioral Bibliotherapy for Mildly and Moderately Depressed Older Adults,”Journal of Consulting and Clinical Psychology 57 (1989): 403–407.
F.Scogin, C.Jamison, and N.Davis, “A Two-Year Follow-up of the Effects of Bibliotherapy for Depressed Older Adults,”Journal of Consulting and Clinical Psychology 58 (1990): 665–667.
F.Scogin, C.Jamison, M.Floyd, and W.Chaplin, “Measuring Learning in Depression Treatment: A Cognitive Bibliotherapy Test,”Cognitive Therapy and Research 22 (1998): 475–482.
N.M.Smith, M.R.Floyd, C.Jamison, and F.Scogin, “Three-Year Follow-up of Bibliotherapy for Depression,”Journal of Consulting and Clinical Psychology 65 (1997): 324–327.
R.J.DeRubeis, S.D.Hollon, J.D.Amsterdam, R.C.Shelton, P.R.Young, R.M.Salomon, J.P.O’Reardon, M.L.Lovett, M.M.Gladis, L.L.Brown, and R.Gallop, “Cognitive Therapy vs.Medications in the Treatment of Moderate to Severe Depression,”Archives of General Psychiatry 62 (2005): 409–416.Web abstract: http://archpsych.ama-assn.org/cgi/content/abstract/62/4/409.
S.D.Hollon, R.J.DeRubeis, R.C.Shelton, J.D.Amsterdam, R.M.Salomon, J.P.O’Reardon, M.L.Lovett, P.R.Young, K.L.Haman, B.B.Freeman, and R.Gallop, “Prevention of Relapse Following Cognitive Therapy vs.Medications in Moderate to Severe Depression,”Archives of General Psychiatry 62 (2005): 417–422.Web abstract: http://archpsych.ama-assn.org/cgi/content/abstract/62/4/417.
As quoted in Medical News Today, July 8, 2005, “Cognitive Therapy as Good as Antidepressants, Effects Last Longer.”Web link: http://medicalnewstoday.com/ medicalnews.php?newsid=22319#.
H.A.Westra and S.H.Stewart, “Cognitive Behavioral Therapy and Pharmacotherapy:Complementary or Contradictory Approaches to the Treatment of Anxiety?”Clinical Psychology Review 18, no.3 (1998): 307–340.
H.A.Westra and S.H.Stewart, “Cognitive Behavioral Therapy and Pharmacotherapy: Complementary or Contradictory Approaches to the Treatment of Anxiety?”Clinical Psychology Review 18, no.3 (1998): 307–340.
J.Mendels, J.L.Stinnett, D.D.Burns, and A.Frazer, “Amine Precursors and Depression,”Archives of General Psychiatry 32 (1975): 22–30.
Hypericum Depression Trial Study Group, “Effect of Hypericum perforatum (St.John’s Wort) in Major Depressive Disorder: A Randomized, Controlled Trial,”Journal of the American Medical Association 287 (2002): 1807–1814.Online summary: http://www.nih.gov/news/pr/apr2002/nccam-09.htm.
I.Kirsch and G.Sapirstein, “Listening to Prozac but Hearing Placebo: A Meta-Analysis of Antidepressant Medication,”Prevention and Treatment 1 (1998), article0002a.Online article: http://journals.apa.org/prevention/volume1/pre0010002a.html.
I.Kirsch, T.J.Moore, A.Scoboria, and S.S.Nicholls, “The Emperor’s New Drugs:An Analysis of Antidepressant Medication Data Submitted to the U.S.Food and Drug Administration,”Prevention and Treatment 5 (2002), article 23.Online article: http://journals.apa.org/prevention/volume5/pre0050023a.html.
S.H.Preskorn, “Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors: An Overview with Emphasis on Pharmacokinetics and Effects on Oxidative Drug Metabolism,”Clinical Pharmacokinetics 32, suppl.1 (1997): 1–21.
I.Kirsch and G.Sapirstein, “Listening to Prozac but Hearing Placebo: A Meta-Analysis of Antidepressant Medication,”Prevention and Treatment 1 (1998), article 0002a.Online article: http://journals.apa.org/prevention/volume1/pre0010002a.html.
I.Kirsch, T.J.Moore, A.Scoboria, and S.S.Nicholls, “The Emperor’s New Drugs: An Analysis of Antidepressant Medication Data Submitted to the U.S.Food and Drug Administration,”Prevention and Treatment 5 (2002), article 23.Online article: http://journals.apa.org/prevention/volume5/pre0050023a.html.
D.O.Antonuccio, W.G.Danton, and G.Y.DeNelsky, “Psychotherapy versus Medication for Depression: Challenging the Conventional Wisdom with Data,”Professional Psychology: Research and Practice 26 (1995): 574–585.
D.O.Antonuccio, W.G.Danton, G.Y.DeNelsky, R.Greenberg, and J.S.Gordon, “Raising Questions about Antidepressants,”Psychotherapy and Psychosomatics 68 (1999): 3–14.
D.O.Antonuccio, D.Burns, and W.G.Danton, “Antidepressants: A Triumph of Marketing over Science?”Prevention and Treatment 5 (2002), article 25.Online article: http://journals.apa.org/prevention/volume5/toc-jul15-02.htm.
E.J.Garland, “Facing the Evidence: Antidepressant Treatment in Children and Adolescents,”Canadian Medical Association Journal 170 (2004): 489–491.
N.Jureidini, C.J.Doecke, P.R.Mansfield, M.M.Haby, D.B.Menkes, and A.L.Tonkin, “Efficacy and Safety of Antidepressants in Children and Adolescents,”British Medical Journal 328 (2004): 879–883.
C.J.Whittington, T.Kendall, P.Fonagy, D.Cottrell, A.Colgrove, and E.Boddington, “Selective Serotonin Reuptake Inhibitors in Childhood Depression: Systematic Review of Published versus Unpublished Data,”Lancet 363 (2004): 1341–1345.
D.Healy, “Lines of Evidence on the Risk of Suicide with Selective Serotonin Reuptake Inhibitors,”Psychotherapy and Psychosomatics 72 (2003): 71–79.
H.A.Westra and S.H.Stewart, “Cognitive Behavioral Therapy and Pharmacotherapy: Complementary or Contradictory Approaches to the Treatment of Anxiety?”Clinical Psychology Review 18, no.3 (1998): 307–340.
D.O.Antonuccio, W.G.Danton, and G.Y.DeNelsky, “Psychotherapy versus Medication for Depression: Challenging the Conventional Wisdom with Data,”Professional Psychology: Research and Practice 26 (1995): 574–585.
R.J.DeRubeis, S.D.Hollon, J.D.Amsterdam, R.C.Shelton, P.R.Young, R.M.Salomon, J.P.O’Reardon, M.L.Lovett, M.M.Gladis, L.L.Brown, and R.Gallop, “Cognitive Therapy vs.Medications in the Treatment of Moderate to Severe Depression,”Archives of General Psychiatry 62 (2005): 409–416.Web abstract: http://archpsych.ama-assn.org/cgi/content/abstract/62/4/409.
S.D.Hollon, R.J.DeRubeis, R.C.Shelton, J.D.Amsterdam, R.M.Salomon, J.P.O’Reardon, M.L.Lovett, P.R.Young, K.L.Haman, B.B.Freeman, and R.Gallop, “Prevention of Relapse Following Cognitive Therapy vs.Medications in Moderate to Severe Depression,”Archives of General Psychiatry 62 (2005): 417–422.Web abstract: http://archpsych.ama-assn.org/cgi/content/abstract/62/4/417.
F.Scogin, D.Hamblin, and L.Beutler, “Bibliotherapy for Depressed Older Adults: A Self-Help Alternative,”The Gerontologist 27 (1987): 383–387.
F.Scogin, C.Jamison, and K.Gochneaut, “The Comparative Efficacy of Cognitive and Behavioral Bibliotherapy for Mildly and Moderately Depressed Older Adults,”Journal of Consulting and Clinical Psychology 57 (1989): 403–407.
F.Scogin, C.Jamison, and N.Davis, “A Two-Year Follow-up of the Effects of Bibliotherapy for Depressed Older Adults,”Journal of Consulting and Clinical Psychology 58 (1990): 665–667.
F.Scogin, C.Jamison, M.Floyd, and W.Chaplin, “Measuring Learning in Depression Treatment: A Cognitive Bibliotherapy Test,”Cognitive Therapy and Research 22 (1998): 475–482.
N.M.Smith, M.R.Floyd, C.Jamison, and F.Scogin, “Three-Year Follow-up of Bibliotherapy for Depression,”Journal of Consulting and Clinical Psychology 65 (1997): 324–327.